Kathleen D. Scott
CIK 1794284 · Chief Financial Officer · last filed 2026-01-06
Kathleen D. Scott is a Chief Financial Officer who has filed 21 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for DRMAW, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $178.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$178.8K
4
21
-$1.24M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DRMAW | Director | 29,584 | $0.01 | $302 | $0 | 8 | 2026-01-06 |
| SPRY | Chief Financial Officer | 18,292 | $9.76 | $178.5K | -$1.24M | 10 | 2026-01-05 |
| NKGen Biotech, Inc. (NKGNW) Delisted | Director | — | $0.03 | — | $0 | 2 | 2024-12-10 |
| Histogen Inc. (CNAT) Delisted | Director | — | — | — | $0 | 1 | 2019-11-19 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | DRMAW | Grant (A) | — | $0 | EDGAR |
| 2026-01-05 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-08-22 | SPRY | Mixed | — | -$168.8K | EDGAR |
| 2025-05-22 | SPRY | Mixed | — | -$630.2K | EDGAR |
| 2025-01-14 | DRMAW | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-12-10 | NKGen Biotech, Inc. (NKGNW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-10-17 | SPRY | Mixed | — | -$181.2K | EDGAR |
| 2024-08-21 | SPRY | Mixed | — | -$181.2K | EDGAR |
| 2024-02-14 | NKGen Biotech, Inc. (NKGNW) Delisted | Grant (A) | — | $0 | EDGAR |